Insulin Glargine U-300 (Toujeo®): A Review

Home Healthc Now. 2016 Mar;34(3):156-7. doi: 10.1097/NHH.0000000000000361.

Authors

Joan S Grant¹, Lucinda J Graven

Affiliation

¹ Joan S. Grant, PhD, RN, is a Professor, School of Nursing, University of Alabama at Birmingham, Birmingham, Alabama. Lucinda J. Graven, PhD, MSN, ARNP, is an Assistant Professor, College of Nursing, Florida State University, Tallahassee, Florida.

PMID: 26925942
DOI: 10.1097/NHH.0000000000000361

No abstract available

Publication types

Review

MeSH terms

Diabetes Mellitus, Type 1 / diagnosis
Diabetes Mellitus, Type 1 / drug therapy*
Diabetes Mellitus, Type 1 / nursing
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / nursing
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Home Health Nursing / methods
Humans
Insulin Glargine / administration & dosage*
Insulin Glargine / adverse effects
Insulin, Long-Acting / administration & dosage
Insulin, Long-Acting / adverse effects
Male
Patient Safety*
Treatment Outcome

Substances

Insulin, Long-Acting
Insulin Glargine